More issues

How to Get Myozyme (Alglucosidase Alfa) Covered by UnitedHealthcare in California: Complete PA Guide & Appeal Process

Answer Box: Getting Myozyme Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Myozyme (alglucosidase alfa) with confirmed Pompe disease diagnosis via genetic testing and enzyme assay, plus specialist evaluation. Submit through the UHC Provider Portal with complete documentation. If denied, file internal appeal within 180 days, then request
6 min read

Blue Cross Blue Shield North Carolina's Coverage Criteria for Naglazyme (Galsulfase): Complete Prior Authorization Guide

Answer Box: Getting Naglazyme Covered by Blue Cross Blue Shield of North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Naglazyme (galsulfase) with confirmed MPS VI diagnosis via enzyme assay or genetic testing. Submit complete documentation including baseline functional assessments (6-minute walk test, stair climbing) through
7 min read

How to Get Kesimpta (Ofatumumab) Covered by UnitedHealthcare in California: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Kesimpta Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Kesimpta (ofatumumab) through OptumRx, with step therapy mandating documented failure of preferred MS treatments first. Submit PA via the UHC Provider Portal or fax to 1-844-403-1027. If denied, file internal appeals within 180 days, then request
6 min read

How to Get Brineura (Cerliponase Alfa) Covered by UnitedHealthcare in California: Appeals Guide with Forms and Timelines

Answer Box: Getting Brineura Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Brineura (cerliponase alfa) with strict CLN2 disease criteria. If denied, California residents can file an Independent Medical Review (IMR) through the DMHC with a 55-70% overturn rate for specialty drugs. First step today: Gather CLN2 diagnosis
5 min read

How to Get Mycapssa (Octreotide Oral) Approved by Cigna in New Jersey: Complete Forms & Appeals Guide

Answer Box: Getting Started with Cigna Coverage for Mycapssa in New Jersey Mycapssa (oral octreotide) requires prior authorization from Cigna, processed through Express Scripts specialty pharmacy. The fastest approval path involves: (1) Your endocrinologist submitting electronic PA via CoverMyMeds with baseline IGF-1 labs and specialist documentation, (2) Setting up Accredo
5 min read